{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:56:31Z","timestamp":1781175391108,"version":"3.54.1"},"reference-count":257,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14760584.2026.2686294","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:54:57Z","timestamp":1780908897000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Progress toward an Epstein-Barr virus vaccine"],"prefix":"10.1080","volume":"25","author":[{"given":"Craig","family":"Laferriere","sequence":"first","affiliation":[{"name":"iosBio Ltd","place":["Haywards Heath, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Bland","sequence":"additional","affiliation":[{"name":"iosBio Ltd","place":["Haywards Heath, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Channon","sequence":"additional","affiliation":[{"name":"iosBio Ltd","place":["Haywards Heath, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Young","sequence":"additional","affiliation":[{"name":"Warwick University","place":["Coventry, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"1","key":"e_1_3_5_3_1","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire SK","year":"2015","unstructured":"Dunmire SK, Hogquist KA, Balfour HH. Infectious mononucleosis. Curr Top Microbiol Immunol. 2015;390(Pt 1):211\u201322.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"e_1_3_5_4_1","first-page":"3","article-title":"Why and how Epstein-Barr virus was discovered 50 years ago","volume":"390","author":"Epstein A","year":"2015","unstructured":"Epstein A. Why and how Epstein-Barr virus was discovered 50 years ago. Curr Top Microbiol Immunol. 2015;390(Pt 1):3\u201315.","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09049-x"},{"issue":"1","key":"e_1_3_5_6_1","first-page":"71","article-title":"Chromatin Structure of Epstein-Barr virus latent episomes","volume":"390","author":"Lieberman PM","year":"2015","unstructured":"Lieberman PM. Chromatin Structure of Epstein-Barr virus latent episomes. Curr Top Microbiol Immunol. 2015;390(Pt 1):71\u2013102.","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_5_7_1","first-page":"1","article-title":"Epstein-Barr virus and Kaposi\u2019s sarcoma herpesvirus\/human herpesvirus 8","volume":"70","author":"IARC","year":"1997","unstructured":"IARC. Epstein-Barr virus and Kaposi\u2019s sarcoma herpesvirus\/human herpesvirus 8. IARC Monogr Eval Carcinog Risks Hum. 1997;70:1\u2013492.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15030714"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.01.247"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aec0501"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1893"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00107507"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.03.040"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3700"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj8222"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-023-00775-5"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00471-9"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.887794"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106337"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/13524585251340812"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.173489"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.02.055"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv290"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000496"},{"key":"e_1_3_5_25_1","unstructured":"Chandramouli S. MRNA-1189 & MRNA-1195. Slides presented at the: investor update. 2024 May 2. Available from: https:\/\/investors.modernatx.com\/events-and-presentations\/Program-Detail\/default.aspx"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.4172\/2469-5653.1000113"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005286"},{"issue":"1","key":"e_1_3_5_28_1","first-page":"71","article-title":"Infectious mononucleosis: rapid evidence review","volume":"107","author":"Sylvester JE","year":"2023","unstructured":"Sylvester JE, Buchanan BK, Silva TW. Infectious mononucleosis: rapid evidence review. Am Fam Physician. 2023;107(1):71\u201378.","journal-title":"Am Fam Physician"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2024.2408465"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.2.6.696-699.1995"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80493-8"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-015534"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu342"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268817002515"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis646"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01138-z"},{"issue":"3","key":"e_1_3_5_37_1","first-page":"166","article-title":"Burkitt\u2019s lymphoma in Africa, a review of the epidemiology and etiology","volume":"7","author":"Orem J","year":"2007","unstructured":"Orem J, Mbidde EK, Lambert B, et al. Burkitt\u2019s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci. 2007;7(3):166\u2013175.","journal-title":"Afr Health Sci"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1619750"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211055120"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13122068"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.e22006"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu144"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1049"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000568"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001623801"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1517\/17530059.2011.618185"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101674"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18065"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020328"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.18502\/ijhoscr.v15i4.7479"},{"issue":"10","key":"e_1_3_5_53_1","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/ajt.13324","article-title":"The impact of EBV status on characteristics and outcomes of post-transplantation lymphoproliferative disorder","volume":"15","author":"Luskin MR","year":"2015","unstructured":"Luskin MR, Heil DS, Tan KS, et al. The impact of EBV status on characteristics and outcomes of post-transplantation lymphoproliferative disorder. Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg. 2015;15(10):2665\u20132673.","journal-title":"Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0270"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-021-06922-2"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-024-10176-9"},{"issue":"2","key":"e_1_3_5_57_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcancer.2012.01.007","article-title":"Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000\u20132011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors","volume":"22","author":"Hildesheim A","year":"2012","unstructured":"Hildesheim A, Wang C-P. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000\u20132011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors. Semin Cancer Biol. 2012;22(2):107\u2013116.","journal-title":"Semin Cancer Biol"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030643"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1122-T"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.09.019"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.583463"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.045"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28402"},{"issue":"3","key":"e_1_3_5_64_1","first-page":"1092","article-title":"Clinicopathological features of Epstein-Barr virus-associated gastric carcinoma: a systematic review and meta-analysis","volume":"24","author":"Qiao Y-W","year":"2019","unstructured":"Qiao Y-W, Zhao XQ, Liu J, et al. Clinicopathological features of Epstein-Barr virus-associated gastric carcinoma: a systematic review and meta-analysis. J Buon Off J Balk Union Oncol. 2019;24(3):1092\u20131099.","journal-title":"J Buon Off J Balk Union Oncol"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07013-x"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03824-y"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-9-38"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2019.1634030"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2011.3385"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-077341"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.22367"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.56.3.188"},{"key":"e_1_3_5_73_1","unstructured":"Boyce AJ. Epstein-Barr virus genome loss from endemic Burkitt lymphoma and its effect on cell phenotype [Internet] [PhD thesis]. University of Birmingham; 2009. Available from: https:\/\/etheses.bham.ac.uk\/id\/eprint\/4731\/"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.1135"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-017-0086-4"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.796933"},{"issue":"18","key":"e_1_3_5_78_1","doi-asserted-by":"crossref","first-page":"e2419689122","DOI":"10.1073\/pnas.2419689122","article-title":"Multiple sclerosis and gut microbiota: lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-an unbiased functional study","volume":"122","author":"Yoon H","year":"2025","unstructured":"Yoon H, Gerdes LA, Beigel F, et al. Multiple sclerosis and gut microbiota: lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-an unbiased functional study. Proc Natl Acad Sci USA. 2025;122(18):e2419689122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231186899"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163239"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1579693"},{"issue":"2","key":"e_1_3_5_82_1","doi-asserted-by":"crossref","first-page":"e000082","DOI":"10.1212\/WN9.0000000000000082","article-title":"Risk of multiple sclerosis among persons with Epstein-Barr virus\u2013positive mononucleosis","volume":"2","author":"Sauver Jl S","year":"2026","unstructured":"Sauver Jl S, Hall SA, Jacobson RM, et al. Risk of multiple sclerosis among persons with Epstein-Barr virus\u2013positive mononucleosis. Neurol Open Access. 2026;2(2):e000082.","journal-title":"Neurol Open Access"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm7930"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.06.010"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2425670122"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf170"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/sji.70016"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0102-3"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200150"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41632"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36901-y"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-10020-2"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213783"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201827"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ady0210"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00187"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.04.014"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgstr.2023.1199687"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.07.003"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.02.071"},{"issue":"12","key":"e_1_3_5_101_1","first-page":"22529","article-title":"The epidemiology and risk factors of inflammatory bowel disease","volume":"8","author":"Ye Y","year":"2015","unstructured":"Ye Y, Pang Z, Chen W, et al. The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med. 2015;8(12):22529\u201322542.","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52195-8"},{"issue":"3","key":"e_1_3_5_103_1","first-page":"258","article-title":"Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases","volume":"29","author":"Kyriakidi KS","year":"2016","unstructured":"Kyriakidi KS, Tsianos VE, Karvounis E, et al. Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases. Ann Gastroenterol Q Publ Hell Soc Gastroenterol. 2016;29(3):258\u2013267.","journal-title":"Ann Gastroenterol Q Publ Hell Soc Gastroenterol"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1997.4121510.x"},{"issue":"3","key":"e_1_3_5_105_1","first-page":"s51","article-title":"Report: economic implications of inflammatory bowel disease and its management","volume":"22","author":"Mehta F","year":"2016","unstructured":"Mehta F. Report: economic implications of inflammatory bowel disease and its management. Am J Manag Care. 2016;22(3 Suppl):s51\u201360.","journal-title":"Am J Manag Care"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3726-1"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2017.08.003"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11081958"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208957"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2025.100269"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101469"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11728"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2103"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.890833"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104593"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041590"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1159\/000503142"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.884878"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032392"},{"issue":"9","key":"e_1_3_5_120_1","first-page":"2349","article-title":"Characterization of proinsulin T cell epitopes restricted by type 1 diabetes-associated HLA class II molecules","volume":"204","author":"Ihantola E-L","year":"2020","unstructured":"Ihantola E-L, Ilmonen H, Kailaanm\u00e4ki A, et al. Characterization of proinsulin T cell epitopes restricted by type 1 diabetes-associated HLA class II molecules. J Immunol Baltim Md 1950. 2020;204(9):2349\u20132359.","journal-title":"J Immunol Baltim Md 1950"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.03.003"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0085"},{"issue":"46","key":"e_1_3_5_123_1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.15585\/mmwr.mm7246a1","article-title":"Trends in the Prevalence of chronic obstructive pulmonary disease among adults aged \u226518 years - United States, 2011\u20132021","volume":"72","author":"Liu Y","year":"2023","unstructured":"Liu Y, Carlson SA, Watson KB, et al. Trends in the Prevalence of chronic obstructive pulmonary disease among adults aged \u226518 years - United States, 2011\u20132021. MMWR Morb Mortal Wkly Rep. 2023;72(46):1250\u20131256.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_5_124_1","doi-asserted-by":"crossref","unstructured":"Nyeo SS Cumming EM Burren OS et al. Population-scale sequencing resolves correlates and determinants of latent Epstein-Barr virus infection. BioRxiv Prepr Serv Biol. 2025:2025.07.18.665549.","DOI":"10.1101\/2025.07.18.665549"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2012.729621"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa235"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00304-2"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2003.09.005"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01132-18"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep03232"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102332"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.830993"},{"issue":"1","key":"e_1_3_5_133_1","first-page":"45","article-title":"Epstein-Barr virus strain variation","volume":"390","author":"Farrell PJ","year":"2015","unstructured":"Farrell PJ. Epstein-Barr virus strain variation. Curr Top Microbiol Immunol. 2015;390(Pt 1):45\u201369.","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005549"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-023-01987-3"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9363750"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00211"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology12070983"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2025.200986"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000239"},{"issue":"1","key":"e_1_3_5_141_1","first-page":"119","article-title":"Epstein-Barr virus: from the detection of sequence polymorphisms to the recognition of viral types","volume":"390","author":"Feederle R","year":"2015","unstructured":"Feederle R, Klinke O, Kutikhin A, et al. Epstein-Barr virus: from the detection of sequence polymorphisms to the recognition of viral types. Curr Top Microbiol Immunol. 2015;390(Pt 1):119\u2013148.","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.29"},{"key":"e_1_3_5_143_1","volume-title":"Epstein Barr virus : one herpes virus: many diseases","author":"M\u00fcnz C","year":"2015","unstructured":"M\u00fcnz C. Epstein Barr virus : one herpes virus: many diseases. Volume 2. Cham: Springer; 2015."},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13032"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01205"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1454"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04432-7"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae244"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1558810"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332161"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0249-7"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010017"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.920467"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0810530106"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01871-16"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7240"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202371119"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-02126-0"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuz023"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-017-0081-7"},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09166-w"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26912-6"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.10.003"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.026"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.14.6324-6332.2000"},{"key":"e_1_3_5_166_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.7.3987-3994.1995"},{"key":"e_1_3_5_167_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb1161"},{"key":"e_1_3_5_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2019.07.026"},{"key":"e_1_3_5_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2009.06.013"},{"key":"e_1_3_5_170_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.5.2979"},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00375-17"},{"key":"e_1_3_5_172_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0436-5"},{"key":"e_1_3_5_173_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511545313"},{"key":"e_1_3_5_174_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003685"},{"key":"e_1_3_5_175_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39706-0"},{"key":"e_1_3_5_176_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1342455"},{"key":"e_1_3_5_177_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.659.bloodjournal862659"},{"key":"e_1_3_5_178_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70501"},{"key":"e_1_3_5_179_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-024-00425-4"},{"key":"e_1_3_5_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2017.07.026"},{"key":"e_1_3_5_181_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14112372"},{"key":"e_1_3_5_182_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1509927"},{"key":"e_1_3_5_183_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032414-112326"},{"key":"e_1_3_5_184_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2023.105443"},{"key":"e_1_3_5_185_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.10.5194-5204.2004"},{"issue":"1","key":"e_1_3_5_186_1","first-page":"151","article-title":"EBV persistence\u2013introducing the virus","volume":"390","author":"Thorley-Lawson DA","year":"2015","unstructured":"Thorley-Lawson DA. EBV persistence\u2013introducing the virus. Curr Top Microbiol Immunol. 2015;390(Pt 1):151\u2013209.","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_5_187_1","doi-asserted-by":"publisher","DOI":"10.3390\/v12080788"},{"key":"e_1_3_5_188_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.92"},{"key":"e_1_3_5_189_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1001145"},{"key":"e_1_3_5_190_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13122344"},{"issue":"32","key":"e_1_3_5_191_1","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1073\/pnas.1901314116","article-title":"Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection","volume":"116","author":"Mrozek-Gorska P","year":"2019","unstructured":"Mrozek-Gorska P, Buschle A, Pich D, et al. Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection. Proc Natl Acad Sci USA. 2019;116(32):16046\u201316055.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_5_192_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39770-1"},{"key":"e_1_3_5_193_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.701611"},{"key":"e_1_3_5_194_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007464"},{"key":"e_1_3_5_195_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1081107"},{"key":"e_1_3_5_196_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.677027"},{"key":"e_1_3_5_197_1","doi-asserted-by":"publisher","DOI":"10.1086\/523813"},{"key":"e_1_3_5_198_1","first-page":"171","article-title":"First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen","volume":"84","author":"Gu SY","year":"1995","unstructured":"Gu SY, Huang TM, Ruan L, et al. First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev Biol Stand. 1995 Jan 1;84:171\u2013177.","journal-title":"Dev Biol Stand"},{"key":"e_1_3_5_199_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181b9d918"},{"key":"e_1_3_5_200_1","doi-asserted-by":"crossref","unstructured":"McCool RS Acreman CM Powell AE et al. Design structure and immunogenicity of a soluble prefusion-stabilized EBV gB antigen. bioRxiv. 2025:2025.05.19.654955.","DOI":"10.1101\/2025.05.19.654955"},{"key":"e_1_3_5_201_1","doi-asserted-by":"crossref","unstructured":"McCallum M Veesler D. Computational design of prefusion-stabilized herpesvirus gB trimers. bioRxiv. 2024:2024.10.23.619923.","DOI":"10.1101\/2024.10.23.619923"},{"key":"e_1_3_5_202_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01597-14"},{"key":"e_1_3_5_203_1","doi-asserted-by":"publisher","DOI":"10.3390\/v7122957"},{"key":"e_1_3_5_204_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.01.010"},{"key":"e_1_3_5_205_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-024-06095-3"},{"key":"e_1_3_5_206_1","unstructured":"Price J Haro B Ruff R et al. inventors; Seattle Children\u2019s Hospital Dba Seattle Children\u2019s Research Institute assignee. Prefusion stabilized ebv gb mutations and uses thereof. World Intellectual Property Organization patent WO2024006930A2. 2024 Jan 4."},{"key":"e_1_3_5_207_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67969-x"},{"key":"e_1_3_5_208_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30169-6"},{"issue":"3","key":"e_1_3_5_209_1","first-page":"485","article-title":"Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals","volume":"63","author":"Epstein MA","year":"1986","unstructured":"Epstein MA, Randle BJ, Finerty S, et al. Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals. Clin Exp Immunol. 1986;63(3):485\u2013490.","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_5_210_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890250209"},{"key":"e_1_3_5_211_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890270210"},{"key":"e_1_3_5_212_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199611)50:3<263::AID-JMV9>3.0.CO;2-7"},{"key":"e_1_3_5_213_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.008"},{"key":"e_1_3_5_214_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01409-07"},{"key":"e_1_3_5_215_1","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2014.27"},{"key":"e_1_3_5_216_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.043"},{"key":"e_1_3_5_217_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf3685"},{"key":"e_1_3_5_218_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.04.102"},{"key":"e_1_3_5_219_1","unstructured":"Nabel GJ Wei C Nguyen L et al. inventors; Sanofi SA assignee. Antigenic Epstein Barr virus polypeptides. United States patent US11617780B2. 2023 Apr 4."},{"key":"e_1_3_5_220_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030540"},{"key":"e_1_3_5_221_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05598-11"},{"key":"e_1_3_5_222_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1293529"},{"key":"e_1_3_5_223_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9030285"},{"key":"e_1_3_5_224_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.071"},{"key":"e_1_3_5_225_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.06.021"},{"key":"e_1_3_5_226_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020169"},{"key":"e_1_3_5_227_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1445209"},{"key":"e_1_3_5_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100658"},{"key":"e_1_3_5_229_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00907-y"},{"key":"e_1_3_5_230_1","volume-title":"Oral presentation & poster presented at the: World Vaccine Congress, Washington 2025","author":"Laferriere C","year":"2025","unstructured":"Laferriere C, Bacon A, Bland E, et al. Oral vaccine against Epstein-Barr virus: systemic and mucosal immunity for prevention of infection. Oral presentation & poster presented at the: World Vaccine Congress, Washington 2025; Washington, DC; 2025 Apr 21."},{"key":"e_1_3_5_231_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21597"},{"key":"e_1_3_5_232_1","doi-asserted-by":"publisher","DOI":"10.1159\/000360223"},{"key":"e_1_3_5_233_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.11.041"},{"issue":"48","key":"e_1_3_5_234_1","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1073\/pnas.1616574113","article-title":"Mouse model for acute Epstein-Barr virus infection","volume":"113","author":"Wirtz T","year":"2016","unstructured":"Wirtz T, Weber T, Kracker S, et al. Mouse model for acute Epstein-Barr virus infection. Proc Natl Acad Sci USA. 2016;113(48):13821\u201313826.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_5_235_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.70257"},{"key":"e_1_3_5_236_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9020116"},{"key":"e_1_3_5_237_1","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2015.1"},{"key":"e_1_3_5_238_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010738"},{"key":"e_1_3_5_239_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-7230-7_22"},{"key":"e_1_3_5_240_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22834-1_10"},{"key":"e_1_3_5_241_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02193"},{"key":"e_1_3_5_242_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900377"},{"key":"e_1_3_5_243_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1289313"},{"key":"e_1_3_5_244_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867918"},{"key":"e_1_3_5_245_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01293-15"},{"key":"e_1_3_5_246_1","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.48"},{"key":"e_1_3_5_247_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2299"},{"key":"e_1_3_5_248_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa654"},{"key":"e_1_3_5_249_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800224115"},{"key":"e_1_3_5_250_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb3611"},{"key":"e_1_3_5_251_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz428"},{"key":"e_1_3_5_252_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002878"},{"key":"e_1_3_5_253_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45381-y"},{"key":"e_1_3_5_254_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00587-6"},{"key":"e_1_3_5_255_1","volume-title":"Primary end-points for prophylactic HPV vaccine trials","author":"IARC HPV Working Group","year":"2014","unstructured":"IARC HPV Working Group. Primary end-points for prophylactic HPV vaccine trials. Lyon FR: International Agency for Research on Cancer; 2014."},{"key":"e_1_3_5_256_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00248-5"},{"key":"e_1_3_5_257_1","unstructured":"Ciaramella G John S Narayanan E et al. inventors; ModernaTx Inc assignee. Epstein-barr virus vaccines. World Intellectual Property Organization patent WO2019103993A1. 2019 May 31."},{"key":"e_1_3_5_258_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.6.1019-1024.2003"},{"key":"e_1_3_5_259_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105424"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2686294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:00:44Z","timestamp":1781172044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2026.2686294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":257,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14760584.2026.2686294"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2026.2686294","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2686294"}}